Pharmacyclics Llc.

This study tested whether adding the drug ibrutinib to standard rituximab therapy helps people with untreated follicular lymphoma live longer without their cancer getting worse. About 445 patients aged 60 or older (or 60-69 with other health issues) took part. The main goal was t…

This study tested the drug ibrutinib in children with chronic graft-versus-host disease (cGVHD), a condition where donor immune cells attack the child's body after a stem cell transplant. The goal was to find the best dose and check safety. 59 children aged 1 to 22 took part. The…